Trials / Recruiting
RecruitingNCT07304505
Probiotics in Adults With Rheumatoid Arthritis
An Open-Label Exploratory Analysis of Commercial Probiotics in Adults With Rheumatoid Arthritis
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Ancilia Biosciences · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical study is to collect data on the effect of probiotic administration on clinical outcomes in rheumatoid arthritis patients. Participants will: * Have a 6-week daily administration of a probiotic * Collect fecal samples every other day during the first 3 weeks of the study and twice weekly over the last 3 weeks * Visit the clinic at Baseline, Week 3 and Week 6 for checkup and testing
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Align Extra Strength Probiotic Supplement | Bifidobacterium longum subsp. longum 35624™ (50mg): 5 x10\^9 (5 billion) live bacteria per capsule |
Timeline
- Start date
- 2025-11-13
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
- First posted
- 2025-12-26
- Last updated
- 2025-12-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07304505. Inclusion in this directory is not an endorsement.